These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 8551623

  • 1. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
    Utz U, Banks D, Jacobson S, Biddison WE.
    J Virol; 1996 Feb; 70(2):843-51. PubMed ID: 8551623
    [Abstract] [Full Text] [Related]

  • 2. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
    Elovaara I, Utz U, Smith S, Jacobson S.
    J Neuroimmunol; 1995 Dec; 63(1):47-53. PubMed ID: 8557824
    [Abstract] [Full Text] [Related]

  • 3. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S.
    J Exp Med; 1993 Jun 01; 177(6):1567-73. PubMed ID: 8496677
    [Abstract] [Full Text] [Related]

  • 4. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Furukawa K, Mori M, Ohta N, Ikeda H, Shida H, Furukawa K, Shiku H.
    J Clin Invest; 1994 Nov 01; 94(5):1830-9. PubMed ID: 7962528
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
    Best I, López G, Talledo M, MacNamara A, Verdonck K, González E, Tipismana M, Asquith B, Gotuzzo E, Vanham G, Clark D.
    AIDS Res Hum Retroviruses; 2011 Nov 01; 27(11):1207-12. PubMed ID: 21453202
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
    Kubota R, Soldan SS, Martin R, Jacobson S.
    J Immunol; 2000 May 15; 164(10):5192-8. PubMed ID: 10799878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.
    Bieganowska K, Höllsberg P, Buckle GJ, Lim DG, Greten TF, Schneck J, Altman JD, Jacobson S, Ledis SL, Hanchard B, Chin J, Morgan O, Roth PA, Hafler DA.
    J Immunol; 1999 Feb 01; 162(3):1765-71. PubMed ID: 9973440
    [Abstract] [Full Text] [Related]

  • 14. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S.
    AIDS Res Hum Retroviruses; 2000 Nov 01; 16(16):1705-9. PubMed ID: 11080814
    [Abstract] [Full Text] [Related]

  • 15. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A, Hasegawa A, Utsunomiya A, Maeda Y, Yamano Y, Masuda M, Shimizu Y, Tamai Y, Sasada A, Zeng N, Choi I, Uike N, Okamura J, Watanabe T, Masuda T, Kannagi M.
    Retrovirology; 2011 Dec 07; 8():100. PubMed ID: 22151736
    [Abstract] [Full Text] [Related]

  • 16. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N.
    Hum Immunol; 2011 Nov 07; 72(11):1001-6. PubMed ID: 21851845
    [Abstract] [Full Text] [Related]

  • 17. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A, Pique C, Garcia Z, Dehée A, Tortevoye P, Désiré N, Gessain A, Chancerel B, Gout O, Lemonnier FA, Cochet M.
    J Infect Dis; 2001 Mar 15; 183(6):857-64. PubMed ID: 11237801
    [Abstract] [Full Text] [Related]

  • 18. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.
    Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E, Takashima H, Kubota R.
    Int J Mol Sci; 2024 Jun 22; 25(13):. PubMed ID: 38999966
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.